Loading company…
Riskpilot
← Back to search
Sign in
Get full access
BIOTRANS AS
AS
Active
Org 929817753
Ole Vigs Gate 16, 0366 Oslo
Freight transport by road · NACE 4941
Est. 2022
94 employees
Watchlist
Share
Download PDF
Full Risika report
Overview
Financials
People & ownership
Related companies
Revenue 2024
NOK 27,2M
+1% vs 2023
EBITDA margin
10.8%
-46% vs 2023
Equity ratio
59.6%
Financial strength
Net profit 2024
NOK 1,5M
-71% vs 2023
EBITDA — year on year
NOK millions
6M
5M
3M
2M
0M
4M
2022
5M
+25%
2023
3M
-40%
2024
Key figures
Annual report 2024
Revenue
NOK 27,2M
+1%
EBITDA
NOK 2,9M
-46%
Net profit
NOK 1,5M
-71%
Total assets
NOK 12M
-4%
Equity
NOK 7,1M
+27%
Employees
94
—
Company information
Legal name
BIOTRANS AS
Org number
929817753
Legal form
Aksjeselskap
NACE code
4941 · Freight transport by road
Founded
12. september 2022
Share capital
NOK 30 000
Employees
94 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets medlemmer hver for seg.
Company purpose
Godstransport på vei og alt hva derved står i forbindelse.
Contact
Address
Ole Vigs Gate 16, 0366 Oslo
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Freight transport by road
Companies in Oslo
All Norway companies
Revenue
NOK millions
0M
8M
16M
23M
31M
25M
2022
27M
2023
27M
2024
EBITDA
NOK millions
0M
1M
3M
4M
6M
4M
2022
5M
2023
3M
2024
Income statement
NOK thousands
Item
2022
2023
2024
Revenue
25 426
27 029
27 192
Staff expenses
−9 439
−10 862
−12 664
EBITDA
4 140
5 378
2 929
Depreciation & amort.
−584
−951
−990
EBIT
3 557
4 427
1 939
Net financials
1
1 802
22
Profit before tax
3 558
6 229
1 962
Tax
780
985
434
Net profit
2 778
5 244
1 528
Balance sheet
NOK thousands
Item
2022
2023
2024
Total assets
11 978
12 435
11 971
Equity
362
5 605
7 133
Long-term debt
8 017
2 672
207
Short-term debt
3 600
4 158
4 632
Total debt
11 616
6 830
4 839
Financial ratios
5-year trend
EBITDA margin
10.8%
This company
15.8%
Market median
-32% vs market
2022
2024
Equity ratio
59.6%
This company
38.2%
Market median
+56% vs market
2022
2024
Return on equity
21.4%
This company
18.4%
Market median
+16% vs market
2022
2024
Net profit margin
5.6%
This company
8.1%
Market median
-31% vs market
2022
2024
Asset turnover
2.27×
This company
1.12×
Market median
+103% vs market
2022
2024
Debt / equity
0.68×
This company
0.62×
Market median
+10% vs market
2022
2024
Annual reports & filings
Annual report 2024
Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
View
PDF
Management
Actively employed in the business
Name
Role
Member since
Current (1)
TO
Trond Ove Lunde
Chief Executive Officer
Chief Executive Officer
2022
Board of directors
Non-executive oversight
Name
Role
Member since
Current (1)
NK
Nina Knapper Lunde
Deputy Chairman
2022
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
Trond Lunde Holding As
Company
100%
100%
2024
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
Trond Lunde Holding As
BIOTRANS AS
(this company)
VIKEN MUSIKK AS
WHOLESALE NORDIC AS
DUETT MUSIKKVERKSTED AS
Board network connections
Board members of BIOTRANS AS also hold positions in
0
other companies.
Person
Role here
Other companies
Trond Ove Lunde
Chief Executive Officer
0 companies
Nina Knapper Lunde
Deputy Chairman
0 companies